Possible montelukast-induced angioedema

American Journal of Health-System Pharmacy

Volumn 66, Issue 19, 2009, Pages 1705-1706

  Sabbagh, Racha ^a   Sheikh Taha, Marwan ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

Angioedema; Antihistamines; Ebastine; Epinephrine; Fexofenadine hydrochloride; Hydroxyzine hydrochloride; Leukotriene antagonists; Montelukast sodium; Sympathomimetic agents; Toxicity; Vitamins

Indexed keywords

ADRENALIN; EBASTINE; FEXOFENADINE; HYDROXYZINE; MONTELUKAST;

ADULT; ALLERGY; ANAMNESIS; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; DYSPNEA; EMERGENCY WARD; EYE SWELLING; FEMALE; HUMAN; OXYGEN SATURATION; PARESTHESIA; PRIORITY JOURNAL;

ACETATES; ANGIOEDEMA; FEMALE; HUMANS; HYPERSENSITIVITY; LEUKOTRIENE ANTAGONISTS; MIDDLE AGED; QUINOLINES;

EID: 70349754591     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080408     Document Type: Article

References (6)

1. Singulair (montelukast sodium) tablets and chewable tablets prescribing information. Whitehouse Station, NJ: Merck & Co.; 2006 Sep.
2. Guilpain P, Viallard JF, Lagarde P et al. Churg-Strauss syndrome in two patients receiving montelukast. Rheumatology. 2002; 41:535-539 (Pubitemid 34567184)
3. Sass DA, Chopra KB, Wu T. A case of montelukast-induced hepatotoxicity. Am J Gastroenterol. 2003; 98:704-705
4. Minciullo PL, Saija A, Bonanno D et al. Montelukast induced generalized urticaria. Ann Pharmacother. 2004; 38:999-1001.
5. Winters M. Initial evaluation and management of patients presenting with acute urticaria or angioedema. www.medscape.com/viewarticle/552643 (accessed 2009 Jun 29).
6. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-245